A self-closing device for implantation within a patient's body includes base material including an inner surface area for securing the base material to a tissue structure, and a plurality of support elements surrounding or embedded in the base material. The support elements are separable laterally within a plane of the base material to accommodate creating an opening through the base material for receiving one or more instruments through the base material, and biased to return laterally towards a relaxed state for self-closing the opening after removing the one or more instruments. The device may be provided as a patch or integrally attached to a tubular graft or in various shapes.

Described herein are cryolipolysis devices, systems, and methods for facilitating percutaneous access to a target blood vessel by performing cryolipolysis on subcutaneous adipose tissue obscuring the target blood vessel (e.g., a vessel used for hemodialysis treatment). Generally, the devices include a cooling member carrying a coolant that cools a selected portion of adipose tissue overlying the target blood vessel to reduce the selected portion of adipose tissue, thereby forming a depression in the adipose tissue and allowing the target blood vessel closer to the surface of the skin. In some variations, the cooling member is placed subcutaneously to directly cool the selected portion of adipose tissue. In other variations, the cooling member is placed external to the patient to indirectly cool the selected portion of adipose tissue through the skin.

A method is provided and may include accessing a terminal branch of an ophthalmic artery through a skin of a head of a subject via a first device, positioning at least one of the first device or a second device within the ophthalmic artery of the subject, and performing an atherectomy of the ophthalmic artery or a junction between the ophthalmic artery and an internal carotid artery of the subject, using the at least one of the first device or the second device, so as to treat a blockage, a stenosis, a lesion, plaque, or other physiology in the ophthalmic artery or the junction between the ophthalmic artery and the internal carotid artery of the subject.

A process of using a dental implant for performing an antral procedure. The dental implant comprising an implant body having a proximal portion, a distal portion and at least one internal passageway whereby fluid communication is provided between at least one proximal opening in said proximal portion and at least a first portion of an outside of a distal end of said distal portion via at least one distal opening at or near said distal end. The dental implant is configured for implantation in a position wherein said at least one distal opening being adjacent to or within the sinus cavity and said at least one proximal opening being adjacent to or within the oral cavity, whereby an oro-antral channel is provided allowing for surgically accessing the sinus cavity from the oral cavity via said at least one internal passageway in a minimally invasive manner.

An access device for placing a medical article within a body space includes a syringe, a needle, and a sheath which are employed together with a guide wire. The sheath can be coaxially and slideably disposed about the needle. During insertion of the sheath over the needle, guide wire and into the body space, the syringe provides a negative pressure to ensure that any air located between the inside diameter of the sheath and the outside diameter of the needle is drawn into the needle rather than into the body space. In certain embodiments, a dilator is coaxially and slideably disposed about the needle and within the sheath.

The disclosure relates to a subcutaneously implanted port device for establishing access to the vascular system of a patient requiring multiple blood treatments over an extended period of time. The systems, devices and methods disclosed herein may reduce miscannulation, promote intra-session hemostasis, and decrease the incidence of bacteremia and sepsis among other improvements and advantages. The devices include a port with a tapered seat for receiving an access tube, the first tapered seat having a proximal portion, a distal portion, and a conical section extending between the proximal portion and the distal portion; and an interface surface configured to engage a blood vessel or a vascular access catheter. The proximal portion of the tapered seat is configured to receive the access tube therethrough, and the tapered seat creates a mismatch fit with a diameter of the access tube when in use for an increase in flow during treatment.

The present disclosure includes disclosure of devices, shunts, systems, and pump systems, as shown and/or described herein. The present disclosure includes disclosure of methods to treat conditions relating to excess bodily fluids and removal of the same, as referenced herein. A device or shunt can comprise a tube or catheter configured to facilitate drainage of fluid from within the abdomen into a portion of the excretory system. A device or shunt can include a cage/mesh at an external opening and can include a filter or membrane/barrier.

A septum for a port is provided, the septum having a top wall and a side wall. The side wall can include a pressure-activated valve element for regulating the flow of fluid across the valve. The curvature of the side wall and the geometry of the sidewall and the housing can be tailored to bias the valve element to open at different pressures during infusion and aspiration. The side wall can also include an extended portion that can function as a suture wing for securing the port within a port pocket.

An intraosseous access device can include a device body, a trocar needle, and an intraosseous catheter removably disposed on the trocar needle. The device body can be configured to enable a user of the access device to manually insert a distal tip of the trocar needle through a skin surface of a body of a patient to an external surface of a bone of the patient. The intraosseous access device can include a first advancement member configured to provide a first distal advancement force sufficient to distally advance a distal tip of the trocar needle and the catheter through a skin surface to an external surface of a bone of a patient, and a second advancement member configured to provide a second distal advancement force sufficient to distally advance the distal tip of the trocar needle and the catheter through the external surface of the bone.

An intraosseous access device can include a device body, a trocar needle coupled to the device body, and an intraosseous catheter removably disposed on the trocar needle. The device body can be configured to enable manual insertion of a distal tip of the trocar needle through a skin surface of a patient to an external surface of a bone of the patient. The intraosseous catheter can include a catheter hub and a cannula slidable with respect to the catheter hub to enable adjustment of a longitudinal length of the intraosseous catheter. The intraosseous access device can further include an advancement mechanism configured to advance the trocar needle and the intraosseous catheter into an internal portion of the bone after the distal tip of the trocar needle and the intraosseous catheter have been inserted through the skin surface of the patient to the external surface of the bone of the patient.